Justine Koenigsberg
Vice President, Investor Relations
Replay available
Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call
Kymera Therapeutics, Inc. (NASDAQ: KYMR) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Nello Mainolfi
Founder, President & CEO
Jared Gollub
Former Chief Medical Officer and Advisor
Terrence Rooney
Chief Medical Officer
Bruce Jacobs
Chief Financial Officer
Thomas Smith
Analyst, Learning Partners
Tasin Ahmad
Analyst, Bank of America
Andy Chen
Analyst, Wolfe Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Kymera Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.431 Good day, everyone. My name is Shell and I will be your conference operator today. 00:00:04.431 -- 00:00:08.673 At this time, I would like to welcome you to the Chimera Therapeutics second quarter 00:00:08.673 -- 00:00:14.836 2026 results call. All lines have been placed on mute to prevent any background noise. 00:00:14.836 -- 00:00:18.438 After the speaker's remarks, there will be a question and answer session. 00:00:18.438 -- 00:00:21.980 If you would like to ask a question during this time, and if you have joined via the 00:00:21.980 -- 00:00:26.262 webinar, please use the raise hand icon, which can be found at the bottom of your webinar 00:00:26.262 -- 00:00:31.205 application. If you have joined by phone, please press star nine on your keypad to raise 00:00:31.205 -- 00:00:36.288 your hand. At this time, I would like to turn the call over to Justine Koenigsberg, 00:00:36.288 -- 00:00:38.529 Vice President, Investor Relations. 00:00:38.529 -- 00:00:41.550 Justine, please go ahead. 00:00:41.771 -- 00:00:46.132 Good morning and welcome to Chimera Therapeutics quarterly update conference call. 00:00:46.132 -- 00:00:50.534 Joining me today with prepared remarks are Nello Mainolfi, our founder, president and 00:00:50.534 -- 00:00:54.095 CEO, and Bruce Jacobs, our chief financial officer. 00:00:54.095 -- 00:00:58.597 We'll also have brief comments from Jared Gollub and Terrence Rooney, our new chief medical 00:00:58.597 -- 00:01:01.968 officer, who will also join us for Q&A. 00:01:01.968 -- 00:01:05.569 Following our prepared remarks, we will open the call for questions from our covering 00:01:05.569 -- 00:01:10.150 analysts. To ensure we have time to hear from everyone, we will limit each analyst to 00:01:10.150 -- 00:01:11.731 one ...